Great work to the team!
Onwards and upwards, this should be easily worth $1.50+ given the EBITDA growth from organic and acquisitions.
https://static1.squarespace.com/static/5abade37e17ba3a10b3ea470/t/5d3e4005eed6280001ad17e1/1564360726757/HLA+-+Canaccord+Report+-+July+17%2C+2019.pdf
$1.45 price target from cannacord, likely higher since then given current developments.
